Free Republic

Jim Chanos says "stunning" executive turnover at Tesla is a bad sign for the company. Elon Musk "may be misleading investors," Chanos.. "I think Elon Musk has crossed the Rubicon in terms of making statements to investors that he might rue later," ... Short-seller Jim Chanos is blasting Elon Musk's leadership at Tesla. ... Musk's announcements about future products. "He said the Roadster will be available in 2020 and Semi [truck] will be entering production next year," Chanos said. "I don't think either of those are going to happen." He believes recent management turnover at the electric car maker is...

Short seller Jim Chanos is bearish on major pharmecutical companies. Warren Buffett is long pharmaceuticals. This creates the interesting situation of the top long investor, Buffett, versus the top short investor, Chanos, being on opposites side of a major trade. Buffett owns more than 3.9 million shares of Sanofi Aventis and he holds 1.51 million shares of GlaxoSmithkline. Chanos recently told an Australian radio station: The US healthcare system is probably the most interesting large group of companies that are heading for major problems that we've seen in a long, long time. Healthcare is growing now at about 10 per...

HEDGE FUND CHIEF SHORT AND $WEET By TERI BUHL and KAJA WHITEHOUSE Posted: 4:37 am November 9, 2008 Renowned short seller Jim Chanos is emerging as a potential front-runner for this year's prize for top hedge-fund performer. According to performance data obtained by The Post, Chanos' short-only fund, Ursus, is up 53.2 percent through the end of October, besting the 30 percent performance Chanos booked in 2007, when he was ranked one of the top 100 traders. For October alone, the $5 billion fund earned its investors a whopping 17.8 percent. Meanwhile, Chanos' long-short fund, Kynikos International, is up 11.16...